-- Days : -- HRS : -- MIN : -- SEC

Register Now →

Subscribe

News
Video
Podcasts
Journals
Conferences
Events
Resources
CE
About AJMC
Subscribe

Spotlight -

Free In-Person Regional Events Focused on Oncology and Population Health

Opinion|Videos|March 5, 2024

Unraveling Type 1 Diabetes: Differences Between Type 1 and Type 2

Robert Gabbay, MD, PhD, delineates key differences between type 1 and type 2 diabetes, including autoimmune antibodies, insulin resistance, and insulin deficiency.

Episodes in this series

Video 1 - "Unraveling Type 1 Diabetes: Differences Between Type 1 and Type 2"

EP. 1 Unraveling Type 1 Diabetes: Differences Between Type 1 and Type 2

Video 2 - "Early-stage Type 1 Diabetes and The Psychological Impact of Progressing to Stage 3"

EP. 2 Early-stage Type 1 Diabetes and The Psychological Impact of Progressing to Stage 3

Video 3 - "Identifying Risk to Enable Early Detection of Type 1 Diabetes "

EP. 3 Identifying Risk to Enable Early Detection of Type 1 Diabetes

Video 4 - "Challenges in Autoantibody Screening for Type 1 Diabetes"

EP. 4 Challenges in Autoantibody Screening for Type 1 Diabetes

Video 5 - "Strategies for Preventing Progression of Early-Stage Type 1 Diabetes"

EP. 5 Strategies for Preventing Progression of Early-Stage Type 1 Diabetes

Video 6 - "Optimal Approaches to Diagnostic Testing for Type 1 Diabetes Mellitus"

EP. 6 Optimal Approaches to Diagnostic Testing for Type 1 Diabetes Mellitus

Video 7 - "Harnessing Continuous Glucose Monitors for Type 1 Diabetes Management + Closing Words"

EP. 7 Harnessing Continuous Glucose Monitors for Type 1 Diabetes Management + Closing Words

Newsletter

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Related Content

Little boy using in haler. | Image credit: WavebreakmediaMicro_stock.adobe.com

Respiratory Biologics Linked to Reduced Asthma Exacerbations Across Patient Groups

BySabrina McCrear

June 24th 2026

Mixed Phase 3 Results for IB6-Targeting ADC Raise Questions on Optimal Use in NSCLC

ByBrooke McCormick

June 23rd 2026

Joseph K. Han, MD

How Upstream Biologics Could Transform CRSwNP Care: Joseph K. Han, MD

BySabrina McCrear,Joseph K. Han, MD

June 23rd 2026

X-ray scan with patient. | Image Credit: DraganaGordic_AdobeStock.jpeg

Familial Pulmonary Fibrosis Linked to Faster Lung Function Decline, UIP Pattern

BySabrina McCrear

June 23rd 2026

Ocrelizumab | Image credit: Semi - stock.adobe.com

Switch to Ocrelizumab Shows Safety in Patients With Relapsing MS

ByJulia Bonavitacola

June 23rd 2026

Trending on AJMC

CDC Officially Ends Hantavirus Response as Outbreak Risk Recedes

ATTR-CM Incidence, Prevalence Rose Sharply in the US

FDA Approves Palbociclib for HR+, HER2+ Breast Cancer Maintenance

First Generic of Priftin Approved by FDA for Tuberculosis Treatment and Prevention

Zanubrutinib Tops Rivals in Real-World CLL Survival Study